I agree look at other biotechnology companies they put in an IND to the FDA like IMUC, NWBO, INO etc. they get it done instantly. BMSN doesn't get anything done and strings people along for years that an IND will eventually be approved.
If it takes BMSN this long just go get an IND approved (if it ever gets approved) imagine how long phase 1 and phase 2 trials will take. I think the CEO here is just stringing people along to keep a salary IMO.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.